Ponzoni, Maurilio

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 1,406

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation

Virus-based gene therapy researchCRISPR and Genetic Engineering

Cited by 571

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

Provasi, E., Genovese, P., Lombardo, A., Magnani, Z., Liu, P.-Q., Reik, A., Chu, V., Paschon, D. E., Zhang, L., Kuball, J., et al. (2012) · Nature Medicine

CAR-T cell therapy researchCRISPR and Genetic Engineering

Cited by 448

Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα–Driven Leukemia

Coltella, N., Valsecchi, R., Ponente, M., Ponzoni, M., & Bernardi, R. (2015) · Clinical Cancer Research

Retinoids in leukemia and cellular processesAcute Myeloid Leukemia Research

Cited by 49

Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis

Biavasco, R., Lettera, E., Giannetti, K., Gilioli, D., Beretta, S., Conti, A., Scala, S., Cesana, D., Gallina, P., Norelli, M., et al. (2021) · Nature Communications

Histiocytic Disorders and TreatmentsTelomeres, Telomerase, and Senescence

Cited by 47

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, A. J. M., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, A. D., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., et al. (2017) · The Lancet Haematology

Lymphoma Diagnosis and TreatmentViral-associated cancers and disorders

Cited by 32

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma

Bordini, J., Bertilaccio, M. T. S., Ponzoni, M., Fermo, I., Chesi, M., Bergsagel, P. L., Camaschella, C., & Campanella, A. (2015) · Haematologica

Multiple Myeloma Research and TreatmentsIron Metabolism and Disorders

Cited by 23

EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine

Valsecchi, R., Coltella, N., Magliulo, D., Bongiovanni, L., Scarfò, L., Ghia, P., Ponzoni, M., & Bernardi, R. (2020) · Open Biology

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 12